Beroni Group

Using Modern Science and Technology to Improve Human Health

cell therapies

Cell Therapies

Focus on developing and innovating the cell therapy business for anti-cancer and anti-aging treatments.

anti-cancer-drugs

Anti-Cancer Drugs

Develop new anti-cancer drugs and actively seeking new collaboration opportunities.

infections-diseases

Infectious Diseases

Develop diagnostic tools for detecting infectious diseases.

e-commerce-icon

E-Commerce

Develop a strong e-commerce platform for sales of pharmaceutical and health care products.

World's Leading Enterprise in Biotechnology Life Sciences Environmental Science

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the U.S.A. with business presence in Australia, China, Japan and the USA. It currently has four core businesses – cell therapies, developing new anti-cancer drugs, e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases.

Beroni Group’s overall strategic goal is to become a world’s leading enterprise in the biotechnology, life sciences, and environmental science industries.

4

Countries in operation

200+

Research scientists

17

Award nominations

50k+

product types

Beroni Australia

Level 16, 175 Pitt Street
Sydney, NSW 2000
Australia

Beroni Tianjin

Level 10/ Building 11
Zhong Bei High Technology Industry Park
XiQing District, Tianjin
China

Beroni Guangdong

1001-7, No. 46 Zhigu Street
Tangjiawan Town, High-tech Zone
Zhuhai
China

Dendrix Inc.

4F, Closepoint Building
3-29-1, Ebisu
Shibya-ku, Tokyo
Japan

Beroni Biotech Inc.

L32, Shinjuku Nomura Building
1-26-2 Nishi Shinjuku-ku
Tokyo 163-0532
Japan

PENAO Pty Ltd

C/- Rupert Myers Building South Wing
Level 2 Gate 14 Barker Street
UNSW, Sydney NSW 2052